Delivery Order SPE2DB22D2006-SPE2DB25FW0QA
Award Date
5/6/25
Potential Completion Date
5/7/25
Potential Value
$3.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,064.40, is for the delivery of 4,568,032,429 units of the BOOSTRIX TDAP vaccine syringe (0.5 mL). The contract is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of April 28, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,092,038 units of the BOOSTRIX TDAP vaccine syringe (0.5 mL). The contract has a firm fixed price of $16,764.30 and a completion date of May 1, 2025. This contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,330.50, is for the delivery of BOOSTRIX TDAP vaccine syringes (0.5ML) with a completion date of May 1, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of 4,565,418,571 units of the BOOSTRIX TDAP vaccine syringe (0.5mL). The contract is a firm-fixed-price delivery order with a ceiling value of $3,866.70 and a period of performance through August 13, 2024. No set-aside was used for this award. AmerisourceBergen is a major pharmaceutical distributor that supplies a wide range of medical commodities to federal agencies,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of 4,560,911,316 units of the BOOSTRIX TDAP Vaccine Syringe 0.5mL. The contract has a firm fixed price of $3,347.23 and a completion date of May 12, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of 4,561,703,444 units of the Boostrix TDAP vaccine syringe, 0.5 ml, at a ceiling value of $50,984.00. The contract has an ultimate completion date of August 7, 2023 and was awarded on August 4, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,443,055 units of the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The order has a ceiling value of $5,322.00 and an ultimate completion date of May 7, 2025. The contract is not set aside and was awarded on May 6, 2025. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,563,955,471 units of the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The $1,265.40 contract has a period of performance through March 14, 2024 and does not have a set-aside designation. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,427.58, is for the delivery of 4,567,957,139 units of the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. This is a firm fixed-price delivery order contract with an ultimate completion date of April 18, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The contract has a ceiling value of $9,572.76 and an ultimate completion date of November 26, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as...